These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2597526)

  • 1. Disappearance of oxidative damage to red blood cell membranes in uremic patients following renal transplant.
    Taccone-Gallucci M; Lubrano R; Belli A; Meloni C; Morosetti M; Meschini L; Elli M; Boffo V; Pisani F; Giardini O
    ASAIO Trans; 1989; 35(3):533-5. PubMed ID: 2597526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative damage to RBC membranes and pentose phosphate shunt activity in hemodialysis patients after suspension of erythropoietin treatment.
    Taccone-Galluci M; Lubrano R; Trapasso E; Clerico A; Latorre P; Meloni C; Morosetti M; Castello MA; Casciani CU
    ASAIO J; 1994; 40(3):M663-6. PubMed ID: 8555597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Administration of GSH has no influence on the RBC membrane: oxidative damage to patients on hemodialysis.
    Taccone-Gallucci M; Lubrano R; Clerico A; Meloni C; Morosetti M; Meschini L; Elli M; Trapasso E; Castello MA; Casciani CU
    ASAIO J; 1992; 38(4):855-7. PubMed ID: 1450486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of autofluorescence of red blood cells (RbCs) in uremic patients as a marker of oxidative damage.
    Stoya G; Klemm A; Baumann E; Vogelsang H; Ott U; Linss W; Stein G
    Clin Nephrol; 2002 Sep; 58(3):198-204. PubMed ID: 12356188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of oxidative damage in serum polyunsaturated fatty acids before and after dialysis in chronic uremic patients.
    Taccone-Gallucci M; Lubrano R; Belli A; Citti G; Morosetti M; Meloni C; Elli M; Mazzarella V; Tozzo C; Meschini L
    Int J Artif Organs; 1989 Aug; 12(8):515-8. PubMed ID: 2807596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pentose-phosphate shunt activity and red blood cell malonyldialdehyde levels in haemodialysis and in CAPD patients.
    Taccone-Gallucci M; Giardini O; Lubrano R; Mazzarella V; Bandino D; Meloni C; Elli M; Citti F; Cozzari M; Buoncristiani U
    Life Support Syst; 1985; 3 Suppl 1():121-4. PubMed ID: 3870550
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence of red blood cell membrane lipid peroxidation in haemodialysis patients.
    Giardini O; Taccone-Gallucci M; Lubrano R; Ricciardi-Tenore G; Bandino D; Silvi I; Ruberto U; Casciani CU
    Nephron; 1984; 36(4):235-7. PubMed ID: 6709116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythrocyte transmembrane electron transfer in haemodialysis patients.
    Matteucci E; Cupisti A; Caprioli R; Battipaglia E; Favilla S; Rindi P; Barsotti G; Giampietro O
    Nutr Metab Cardiovasc Dis; 2007 May; 17(4):288-93. PubMed ID: 17434051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of alpha-tocopherol administration on red blood cell membrane lipid peroxidation in hemodialysis patients.
    Giardini O; Taccone-Gallucci M; Lubrano R; Ricciardi-Tenore G; Bandino D; Silvi I; Paradisi C; Mannarino O; Citti G; Elli M
    Clin Nephrol; 1984 Mar; 21(3):174-7. PubMed ID: 6705279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Red blood cell membrane lipid peroxidation and resistance to erythropoietin therapy in hemodialysis patients.
    Gallucci MT; Lubrano R; Meloni C; Morosetti M; Manca di Villahermosa S; Scoppi P; Palombo G; Castello MA; Casciani CU
    Clin Nephrol; 1999 Oct; 52(4):239-45. PubMed ID: 10543326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is erythrocyte damage prevented by gardos effect in hemodialyzed uremic patients?
    Agroyannis B; Paraskevopoulos A; Kopelias I; Tzanatos H; Kapetanaki A; Tsomi A
    Artif Organs; 2000 Sep; 24(9):743-5. PubMed ID: 11012545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uremia and Inadequate Oxygen Supply Induce Eryptosis and Intracellular Hypoxia in Red Blood Cells.
    Dias GF; Tozoni SS; Bohnen G; Grobe N; Rodrigues SD; Meireles T; Nakao LS; Pecoits-Filho R; Kotanko P; Moreno-Amaral AN
    Cell Physiol Biochem; 2021 Jul; 55(4):449-459. PubMed ID: 34259420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of different hemodialysis membranes on red blood cell susceptibility to oxidative stress.
    Lucchi L; Bergamini S; Botti B; Rapanà R; Ciuffreda A; Ruggiero P; Ballestri M; Tomasi A; Albertazzi A
    Artif Organs; 2000 Jan; 24(1):1-6. PubMed ID: 10677150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte susceptibility to oxidative stress in chronic renal failure patients under different substitutive treatments.
    Lucchi L; Bergamini S; Iannone A; Perrone S; Stipo L; Olmeda F; Caruso F; Tomasi A; Albertazzi A
    Artif Organs; 2005 Jan; 29(1):67-72. PubMed ID: 15644086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On-line HFR and removal of uremic toxins inducing the loss of phospholipidic asymmetry of the erythrocyte membrane].
    Sirolli V; Cappelli P; Amoroso L; Di Liberato L; Muscianese P; Santarelli P; Del Rosso G; Bonomini M
    G Ital Nefrol; 2004; 21 Suppl 30():S208-11. PubMed ID: 15750987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of hypoxia and uremia on oxidative stress on erythrocytes from hemodialysis patients.
    Dias GF; Tozoni SS; Bohnen G; van Spitzenbergen BAK; Grobe N; Nakao LS; Pecoits-Filho R; Kotanko P; Moreno-Amaral AN
    Cell Biochem Funct; 2022 Dec; 40(8):856-864. PubMed ID: 36121199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Polyunsaturated Fatty Acid Metabolites, the Protective Effect of 4-hydroxytyrosol on Human Red Blood Cell Membranes and Oxidative Damage (4-hydroxyalkenals) Compatible in Hypertriglyceridemic Patients?
    Gallo G; Bruno R; Taranto A; Martino G
    Pharmacogn Mag; 2017 Oct; 13(Suppl 3):S561-S566. PubMed ID: 29142415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Red blood cell calcium homeostasis in patients with end-stage renal disease.
    Gafter U; Malachi T; Barak H; Djaldetti M; Levi J
    J Lab Clin Med; 1989 Sep; 114(3):222-31. PubMed ID: 2527934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative injury to erythrocytes, cell rigidity and splenic hemolysis in hemodialyzed patients before and during erythropoietin treatment.
    Zachée P; Ferrant A; Daelemans R; Coolen L; Goossens W; Lins RL; Couttenye M; De Broe ME; Boogaerts MA
    Nephron; 1993; 65(2):288-93. PubMed ID: 8247195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glyoxalase I deficiency is associated with an unusual level of advanced glycation end products in a hemodialysis patient.
    Miyata T; van Ypersele de Strihou C; Imasawa T; Yoshino A; Ueda Y; Ogura H; Kominami K; Onogi H; Inagi R; Nangaku M; Kurokawa K
    Kidney Int; 2001 Dec; 60(6):2351-9. PubMed ID: 11737610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.